v3.26.3
Stock-Based Compensation (Tables)
 9 Months Ended
Sep. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of 2018 ASHM Plan Amendments

 

Shareholder

Approval Event

 

2018 Plan (as adopted

and amended)

 

Number of

Awards Approved

  

Cumulative

Awards Approved

 
2018 ASHM  2018 Plan Adoption   12,000    12,000 
2019 ASHM  Amendment #1   5,333    17,333 
2020 ASHM  Amendment #2   11,111    28,444 
2021 ASHM  Amendment #3   34,222    62,666 
2023 ASHM  Amendment #4   68,666    131,332 
2025 ASHM  Amendment #5   133,333    264,665 
2026 ASHM  Amendment #6   1,000,000    1,264,665 
Schedule of Stock Options Awards and Restricted Stock Grants

 

   Stock Options   Weighted 
  

Options

Outstanding

  

Weighted

Average

Exercise

Price

  

Average

Contractual

Terms of

Equity Awards

(in years)

 
Stock options outstanding at January 1, 2026   18,695   $15.68      
                
Stock options granted   242,364   $3.95      
                
Stock options terminated   (2,413)  $4.31      
                
Stock options outstanding at September 30, 2026   258,646   $4.31    9.5 
                
Stock options exercisable at September 30, 2026   135,560   $5.42    9.4 
                
Aggregate intrinsic value of stock options exercisable at September 30, 2026  $-           
Schedule of Assumptions Used to Determine Fair Value of Options Granted

Schedule of Assumptions Used to Determine Fair Value of Options Granted

 

   For the Nine Months Ended September 30,
   2026   2025 
Risk-free interest rate   4.19%   4.22% to 4.55%
Expected volatility   123%   111 to 123%
Expected life (in years)   9.0    9.0 to 10.0 
Expected dividend yield   0.0%   0.0%